University of Toledo, Endocrinology FellowshipToledo, Ohio, United States
Disclosure information not submitted.
SAT-610 - Euglycemic Diabetic Ketoacidosis after GLP-1 Receptor Agonist Initiation in A Patient Receiving Chronic SGLT2 Inhibitor Therapy
Saturday, June 13, 20269:30 AM - 4:30 PM CT